UCLA Department of Family Medicine

12/10/2020

People with atrial fibrillation whose doctor recommended a blood thinner are invited to participate in a 45-minute voluntary research interview.

You will receive $50 dollars for sharing your thoughts and opinions about atrial fibrillation treatment.

See if you qualify!
https://uclahs.az1.qualtrics.com/jfe/form/SV_3W2Z85sMT9lvNlz

12/08/2020

Derjung Mimi Tarn, MD, PhD from the Department of Family Medicine, University of California, Los Angeles (UCLA) and Janice B. Schwartz, MD from the Department of Medicine, University of California, San Francisco (UCSF) invite you to participate in a $50 paid research study on Patient Perspectives about a Blood Thinner for Atrial Fibrillation.

This study investigates how patients with atrial fibrillation make decisions about their medication, specifically their blood thinners. Your thoughts and opinions will help us understand how patients think about their blood thinners.

You may be eligible for this study if:

- You are aged 18 or over
- You were prescribed a blood thinner for atrial fibrillation, palpitations, and/or irregular heartbeat

If you choose to participate, you will take part in a 45-minute phone interview about your thoughts and opinions. You will receive a $50 gift card after your finish your interview.

If you are interested in participating in this study, please follow this link to see if you are eligible:
https://uclahs.az1.qualtrics.com/jfe/form/SV_3W2Z85sMT9lvNlz

You can also email Kevin Shih, project coordinator [email protected], or call 310-794-8242, to learn more about the study.

10/15/2020

https://www.reuters.com/article/us-health-anticoagulants-idUSKBN1X7285

"Almost all of [the 791] patients [who participated in the study] used over-the-counter medicines, and 33% of them took at least one nonprescription drug daily or most days of the week with the potential to cause dangerous side effects when combined with apixaban. And almost 7% of them regularly took two or more over-the-counter medicines that could be a dangerous mix with apixaban."

People taking blood-thinning medications often use over-the-counter (OTC) medicines with the potential to cause dangerous internal bleeding, a recent study suggests.